These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 37256584)

  • 1. Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies.
    Palitsky R; Kaplan DM; Peacock C; Zarrabi AJ; Maples-Keller JL; Grant GH; Dunlop BW; Raison CL
    JAMA Psychiatry; 2023 Jul; 80(7):743-749. PubMed ID: 37256584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spiritual health practitioners' contributions to psychedelic assisted therapy: A qualitative analysis.
    Peacock C; Mascaro JS; Brauer E; Zarrabi AJ; Dunlop BW; Maples-Keller JL; Grant GH; Raison CL; Rab F; Palitsky R
    PLoS One; 2024; 19(1):e0296071. PubMed ID: 38166057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care.
    Ross S; Agrawal M; Griffiths RR; Grob C; Berger A; Henningfield JE
    Neuropharmacology; 2022 Sep; 216():109174. PubMed ID: 35772523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.
    Gobbi G; Inserra A; Greenway KT; Lifshitz M; Kirmayer LJ
    Transcult Psychiatry; 2022 Oct; 59(5):718-724. PubMed ID: 36263521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychedelics and Psychotherapy.
    Nayak S; Johnson MW
    Pharmacopsychiatry; 2021 Jul; 54(4):167-175. PubMed ID: 33285578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.
    Moreton SG; Szalla L; Menzies RE; Arena AF
    Psychopharmacology (Berl); 2020 Jan; 237(1):21-32. PubMed ID: 31784805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.
    Beaussant Y; Tulsky J; Guérin B; Schwarz-Plaschg C; Sanders JJ;
    J Palliat Med; 2021 Nov; 24(11):1657-1666. PubMed ID: 33848208
    [No Abstract]   [Full Text] [Related]  

  • 10. Spiritually and religiously integrated group psychotherapy: a systematic literature review.
    Viftrup DT; Hvidt NC; Buus N
    Evid Based Complement Alternat Med; 2013; 2013():274625. PubMed ID: 24288557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy.
    Gukasyan N; Nayak SM
    Transcult Psychiatry; 2022 Oct; 59(5):652-664. PubMed ID: 33499762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.
    Niles H; Fogg C; Kelmendi B; Lazenby M
    BMC Palliat Care; 2021 Dec; 20(1):191. PubMed ID: 34930220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelic Group Therapy.
    Gasser P
    Curr Top Behav Neurosci; 2022; 56():23-34. PubMed ID: 35091980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelic-assisted therapies: The past, and the need to move forward responsibly.
    Gardner J; Carter A; O'Brien K; Seear K
    Int J Drug Policy; 2019 Aug; 70():94-98. PubMed ID: 31136924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelics and Evidence-based Psychotherapy: A Systematic Review with Recommendations for Advancing Psychedelic Therapy Research.
    Leone L; McSpadden B; DeMarco A; Enten L; Kline R; Fonzo GA
    Psychiatr Clin North Am; 2024 Jun; 47(2):367-398. PubMed ID: 38724126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology.
    Miceli McMillan R; Fernandez AV
    Aust N Z J Psychiatry; 2023 Jun; 57(6):783-788. PubMed ID: 36384307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychedelic-assisted psychotherapy in palliative medicine].
    Schaller A; Bourquin G; Amorim Araujo I; Ljuslin M
    Rev Med Suisse; 2023 Dec; 19(855):2395-2398. PubMed ID: 38117108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors.
    Ponomarenko P; Seragnoli F; Calder A; Oehen P; Hasler G
    J Psychopharmacol; 2023 Jul; 37(7):660-678. PubMed ID: 36855289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey.
    Reynolds LM; Barnett B; Weleff J; Morunga E; Wells A; Stack A; Akroyd A; Hoeh N; Sundram F; Muthukumaraswamy S; Lawrence N; Evans WJ
    Palliat Support Care; 2022 Nov; ():1-10. PubMed ID: 36325995
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.